成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

  1. Cell Cycle/DNA Damage
  2. DNA Alkylator/Crosslinker
  3. Carmustine

Carmustine  (Synonyms: 卡莫司汀; BCNU)

目錄號: HY-13585 純度: 99.91%
COA 產(chǎn)品使用指南 技術(shù)支持

Carmustine 是一種抗腫瘤化療劑,為 DNARNA 的烷化劑 (alkylator)。

MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)

Carmustine Chemical Structure

Carmustine Chemical Structure

CAS No. : 154-93-8

1.  客戶無需承擔(dān)相應(yīng)的運輸費用。

2.  同一機(jī)構(gòu)(單位)同一產(chǎn)品試用裝僅限申領(lǐng)一次,同一機(jī)構(gòu)(單位)一年內(nèi)

     可免費申領(lǐng)三個不同產(chǎn)品的試用裝。

3.  試用裝只面向終端客戶

規(guī)格 價格 是否有貨 數(shù)量
10 mM * 1 mL in DMSO ¥308
In-stock
1 mg ¥120
In-stock
5 mg ¥280
In-stock
10 mg ¥400
In-stock
50 mg ¥830
In-stock
100 mg ¥1500
In-stock
500 mg ¥4000
In-stock
1 g   詢價  
5 g   詢價  

* Please select Quantity before adding items.

Customer Review

Other Forms of Carmustine:

  • 生物活性

  • 實驗參考方法

  • 純度 & 產(chǎn)品資料

  • 參考文獻(xiàn)

生物活性

Carmustine is an antitumor chemotherapeutic agent, which works by akylating DNA and RNA.

IC50 & Target

DNA Alkylator[1]

細(xì)胞效力
(Cellular Effect)
Cell Line Type Value Description References
A 172 IC50
18 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay
[PMID: 2391696]
A-427 IC50
8 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of A427Mer- cell line of lung using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of A427Mer- cell line of lung using the MTT Cytotoxicity Assay
[PMID: 2391696]
A498 IC50
110 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of A498Rem- renal cell line using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of A498Rem- renal cell line using the MTT Cytotoxicity Assay
[PMID: 2391696]
A549 IC50
90 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of A549Rem- cell line of lung using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of A549Rem- cell line of lung using the MTT Cytotoxicity Assay
[PMID: 2391696]
Astrocyte EC50
54.8 μM
Compound: 1, BCNU, Carmustine
Cytotoxicity against Rattus norvegicus Sprague-Dawley (rat) astrocytes after 4 days by cresylecth violet-staining method
Cytotoxicity against Rattus norvegicus Sprague-Dawley (rat) astrocytes after 4 days by cresylecth violet-staining method
10.1007/s00044-010-9356-8
C6 EC50
4.8 μM
Compound: 1, BCNU, Carmustine
Cytotoxicity against Rattus norvegicus (rat) C6 cells after 4 days by cresylecth violet-staining method
Cytotoxicity against Rattus norvegicus (rat) C6 cells after 4 days by cresylecth violet-staining method
10.1007/s00044-010-9356-8
CCD 19Lu IC50
300 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of CCD-19Lu fibroblasts cell line using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of CCD-19Lu fibroblasts cell line using the MTT Cytotoxicity Assay
[PMID: 2391696]
DOD-1 IC50
37 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of DOD-1 breast cell line using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of DOD-1 breast cell line using the MTT Cytotoxicity Assay
[PMID: 2391696]
HL-60 IC50
30.5 μM
Compound: BCNU
Cytotoxicity against Homo sapiens (human) HL60 cells after 96 hr by MTT assay
Cytotoxicity against Homo sapiens (human) HL60 cells after 96 hr by MTT assay
10.1007/s00044-011-9778-y
L1210 ED50
4 μM
Compound: BCNU
Cytotoxicity against mouse L1210 cells after 72 hrs by coulter counter analysis
Cytotoxicity against mouse L1210 cells after 72 hrs by coulter counter analysis
[PMID: 563461]
LOX IMVI IC50
7 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of LOX melanoma cell line using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of LOX melanoma cell line using the MTT Cytotoxicity Assay
[PMID: 2391696]
Malme-3M IC50
20 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of MALME-3M melanoma cell line using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of MALME-3M melanoma cell line using the MTT Cytotoxicity Assay
[PMID: 2391696]
MCF7 IC50
4.5 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of MCF-7 breast cell line using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of MCF-7 breast cell line using the MTT Cytotoxicity Assay
[PMID: 2391696]
NCH89 IC50
615 μM
Compound: Carmustine
Antiproliferative activity against human NCH-89 cells assessed as BrdU incorporation after 48 hrs
Antiproliferative activity against human NCH-89 cells assessed as BrdU incorporation after 48 hrs
[PMID: 20329733]
NCI/ADR-RES IC50
20 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of MCF-7ADR breast cell line using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of MCF-7ADR breast cell line using the MTT Cytotoxicity Assay
[PMID: 2391696]
NCI-H125 IC50
9 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of H125 cell line of lung using the Microculture Tetrazolium (MTT) Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of H125 cell line of lung using the Microculture Tetrazolium (MTT) Cytotoxicity Assay
[PMID: 2391696]
NCI-H23 IC50
5 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of H23 cell line of lung using the Microculture Tetrazolium (MTT) Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of H23 cell line of lung using the Microculture Tetrazolium (MTT) Cytotoxicity Assay
[PMID: 2391696]
NCI-H322M IC50
60 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of H322M cell line of lung using the Microculture Tetrazolium (MTT) Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of H322M cell line of lung using the Microculture Tetrazolium (MTT) Cytotoxicity Assay
[PMID: 2391696]
NCI-H358 IC50
98 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of H358M cell line of lung using the Microculture Tetrazolium (MTT) Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of H358M cell line of lung using the Microculture Tetrazolium (MTT) Cytotoxicity Assay
[PMID: 2391696]
NCI-H460 IC50
80 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of H460 cell line of lung using the Microculture Tetrazolium (MTT) Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of H460 cell line of lung using the Microculture Tetrazolium (MTT) Cytotoxicity Assay
[PMID: 2391696]
NCI-H520 IC50
20 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of H522 cell line of lung using the Microculture Tetrazolium (MTT) Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of H522 cell line of lung using the Microculture Tetrazolium (MTT) Cytotoxicity Assay
[PMID: 2391696]
OVCAR-3 IC50
15 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of OVCAR-3 ovarian cell line using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of OVCAR-3 ovarian cell line using the MTT Cytotoxicity Assay
[PMID: 2391696]
OVCAR-4 IC50
18 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of OVCAR-4 ovarian cell line using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of OVCAR-4 ovarian cell line using the MTT Cytotoxicity Assay
[PMID: 2391696]
SF-126 IC50
20 μM
Compound: BCNU
Cytotoxicity against human SF126 cells expressing low level of AGT assessed as cell survival after 24 hrs by CCK8 assay
Cytotoxicity against human SF126 cells expressing low level of AGT assessed as cell survival after 24 hrs by CCK8 assay
[PMID: 27041398]
SF-126 IC50
25 μM
Compound: BCNU
Cytotoxicity against human SF126 cells expressing low level of AGT assessed as cell survival after 24 hrs by CCK8 assay in presence of O6-BG
Cytotoxicity against human SF126 cells expressing low level of AGT assessed as cell survival after 24 hrs by CCK8 assay in presence of O6-BG
[PMID: 27041398]
SF-126 IC50
55 μM
Compound: BCNU
Cytotoxicity against AGT-deficient human SF126 cells assessed as reduction in cell viability pretreated with O6-BG for 2 hrs followed by addition of compound measured after 24 hrs by CCK8 assay
Cytotoxicity against AGT-deficient human SF126 cells assessed as reduction in cell viability pretreated with O6-BG for 2 hrs followed by addition of compound measured after 24 hrs by CCK8 assay
[PMID: 28197307]
SF-126 IC50
85 μM
Compound: BCNU
Cytotoxicity against AGT-deficient human SF126 cells assessed as reduction in cell viability measured after 24 hrs by CCK8 assay
Cytotoxicity against AGT-deficient human SF126 cells assessed as reduction in cell viability measured after 24 hrs by CCK8 assay
[PMID: 28197307]
SK-MEL-5 IC50
27 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of SK-MEL-5 melanoma cell line using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of SK-MEL-5 melanoma cell line using the MTT Cytotoxicity Assay
[PMID: 2391696]
TE-671 IC50
25 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of TE-671 cell line of central nervous system (CNS)using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of TE-671 cell line of central nervous system (CNS)using the MTT Cytotoxicity Assay
[PMID: 2391696]
U-251 IC50
15 μM
Compound: BCNU
Evaluated for the inhibitory concentration required to cause growth inhibition of U251 cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay
Evaluated for the inhibitory concentration required to cause growth inhibition of U251 cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay
[PMID: 2391696]
U-87MG ATCC IC50
1.42 μM
Compound: BCNU
In vitro inhibitory concentration against growth of U87MG glioblastoma cell line in clonogenic survival assay after 24 hr
In vitro inhibitory concentration against growth of U87MG glioblastoma cell line in clonogenic survival assay after 24 hr
[PMID: 15603970]
U-87MG ATCC IC50
3.9 μg/mL
Compound: BCNU
Cytotoxicity against Homo sapiens (human) U87 cells by MTT assay
Cytotoxicity against Homo sapiens (human) U87 cells by MTT assay
10.1007/s00044-012-0249-x
U-87MG ATCC IC50
3.9 μg/mL
Compound: Carmustine
Antiproliferative activity against human U87 cells assessed as reduction in cell viability by MTT assay
Antiproliferative activity against human U87 cells assessed as reduction in cell viability by MTT assay
[PMID: 33276991]
U-937 IC50
12.3 μM
Compound: BCNU
Cytotoxicity against Homo sapiens (human) U937 cells after 96 hr by MTT assay
Cytotoxicity against Homo sapiens (human) U937 cells after 96 hr by MTT assay
10.1007/s00044-011-9778-y
體外研究
(In Vitro)

Carmustine 是一種抗腫瘤化療劑。Carmustine (8, 80, and 800 μM) 降低大鼠神經(jīng)膠質(zhì)腫瘤細(xì)胞質(zhì)和完整細(xì)胞中 2-氨基芴 (AF) 和對氨基苯甲酸 (PABA) 的 N-乙酰轉(zhuǎn)移酶 (NAT) 活性。在大鼠神經(jīng)膠質(zhì)瘤細(xì)胞中,DNA-AF 加合物增加,Carmustine 減少 DNA-AF 加合物的形成[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

體內(nèi)研究
(In Vivo)

Carmustine (BCNU;25 mg/kg,ip) 與對照組相比,導(dǎo)致更高水平的肝臟重量與體重和血漿結(jié)合膽紅素的 rhe 比值,以及更低的膽汁流量、氧化谷胱甘肽水平 (GSSG) 和還原谷胱甘肽 (GSH)/GSSG 值[2]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial
分子量

214.05

Formula

C5H9Cl2N3O2

CAS 號
性狀

<30°C 固體,>30°C 液體

顏色

White to yellow

中文名稱

卡莫司??;卡氮芥;亞硝脲氮芥;氯乙亞硝脲;卡莫斯汀;卡莫司丁

運輸條件

Room temperature in continental US; may vary elsewhere.

儲存方式

-20°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶解性數(shù)據(jù)
細(xì)胞實驗: 

DMSO 中的溶解度 : 100 mg/mL (467.18 mM; 超聲助溶; 吸濕的 DMSO 對產(chǎn)品的溶解度有顯著影響,請使用新開封的 DMSO)

H2O 中的溶解度 : 100 mg/mL (467.18 mM; 超聲助溶)

配制儲備液
濃度 溶劑體積 質(zhì)量 1 mg 5 mg 10 mg
1 mM 4.6718 mL 23.3590 mL 46.7181 mL
5 mM 0.9344 mL 4.6718 mL 9.3436 mL
查看完整儲備液配制表

* 請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;一旦配成溶液,請分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效
儲備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C儲存時,請在6個月內(nèi)使用,-20°C儲存時,請在1個月內(nèi)使用。

* 備注:如您選擇水作為儲備液,請稀釋至工作液后,再用 0.22 μm 的濾膜過濾除菌后使用。

  • 摩爾計算器

  • 稀釋計算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質(zhì)量
=
濃度
×
體積
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

濃度 (start)

C1

×
體積 (start)

V1

=
濃度 (final)

C2

×
體積 (final)

V2

動物實驗:

請根據(jù)您的 實驗動物和給藥方式 選擇適當(dāng)?shù)娜芙夥桨浮?

以下溶解方案都請先按照 In Vitro 方式配制澄清的儲備液,再依次添加助溶劑:
——為保證實驗結(jié)果的可靠性,澄清的儲備液可以根據(jù)儲存條件,適當(dāng)保存;體內(nèi)實驗的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用;
以下溶劑前顯示的百分比是指該溶劑在您配制終溶液中的體積占比;如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的方式助溶

  • 方案 一

    請依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.08 mg/mL (9.72 mM); 澄清溶液

    此方案可獲得 ≥ 2.08 mg/mL(飽和度未知)的澄清溶液。

    1 mL 工作液為例,取 100 μL 20.8 mg/mL 的澄清 DMSO 儲備液加到 400 μL PEG300 中,混合均勻;再向上述體系中加入 50 μL Tween-80,混合均勻;然后再繼續(xù)加入 450 μL 生理鹽水 定容至 1 mL。

    生理鹽水的配制:將 0.9 g 氯化鈉,溶解于 ddH?O 并定容至 100 mL,可以得到澄清透明的生理鹽水溶液。
  • 方案 二

    請依序添加每種溶劑: 10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.08 mg/mL (9.72 mM); 澄清溶液

    此方案可獲得 ≥ 2.08 mg/mL(飽和度未知)的澄清溶液。

    1 mL 工作液為例,取 100 μL 20.8 mg/mL 的澄清 DMSO 儲備液加到 900 μL 20% 的 SBE-β-CD 生理鹽水水溶液 中,混合均勻。

    2 g SBE-β-CD(磺丁基醚 β-環(huán)糊精)粉末定容于 10 mL 的生理鹽水中,完全溶解至澄清透明。

以下溶解方案,請直接配制工作液。建議現(xiàn)用現(xiàn)配,在短期內(nèi)盡快用完。 以下溶劑前顯示的百分比是指該溶劑在您配制終溶液中的體積占比; 如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的方式助溶。

  • 方案 一

    請依序添加每種溶劑: PBS

    Solubility: 100 mg/mL (467.18 mM); 澄清溶液; 超聲助溶

動物溶解方案計算器
請輸入動物實驗的基本信息:

給藥劑量

mg/kg

動物的平均體重

g

每只動物的給藥體積

μL

動物數(shù)量

由于實驗過程有損耗,建議您多配一只動物的量
計算結(jié)果
工作液所需濃度 : mg/mL
該產(chǎn)品水溶性佳,請具體參考實測 水 / PBS / Saline 中的溶解度數(shù)據(jù)。
您所需的儲備液濃度超過該產(chǎn)品的實測溶解度,如有需要,請與 MCE 中國技術(shù)支持聯(lián)系。
純度 & 產(chǎn)品資料

純度: 99.91%

參考文獻(xiàn)
Kinase Assay
[1]

The determination of Acetyl-CoAdependent N-acetylation of 2-aminofluorene (AF) and p-aminobenzoic acid (PABA) are performed. Incubation mixtures in the assay system consists of a total volume of 90 μL: glial tumor cells cytosols, diluted as required, in 50 μL of lysis buffer (20 mM Tris/HCl, pH 7.5, 1 mM DTT and 1 mM EDTA), 20 μL of an Acetyl-CoA recycling mixture of 50 mM Tris-HCl (pH7.5), 0.2 mM EDTA, 2 mM DTT, 15 mM acetylcamitine, 2U/mL carnitine acetyltransferase, and AF or PABA at specific concentrations. The reactions are started by addition of 20 μL of Acetyl-CoA. The control reactions have 20 μL distilled water in place of Acetyl-CoA. For the single point activity measurements, the final concentration of AF or PABA is 0.1 mM and AcCoA is 0.5 mM. The reaction mixtures with or without specific concentrations of Carmustine and lomustine are incubated at 37°C for 10 min and stopped with 50 μL of 20% trichloroacetic acid for the PABA reactions, and 100 μL of acetonitrile for the AF reactions. All of the reactions (experiments and controls) are run in triplicate[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Administration
[2]

Rats[2]
Individual rats are weighted prior to enter the study; their weights are recorded, and they are randomLy assigned to four groups. Group I (saline group); This group consists of 12 rats. These rats are injected with 2 mL/kg of saline intraperitoneally (IP) 48 h before the study, being included by the study 48 h later. Group II (corn oil group) consists of 15 rats. These rats are injected with 2 mL/kg of corn oil (vehicle) IP 48 h before the study. Group III (Carmustine group) consists of 16 rats. These rats are injected with 1 mL per day of saline IP, administered at the same hour of the day as a single-dose for 3 days. Twelve hours after the first dose of saline, corn oil 2 mL/kg + Carmustine 25 mg/kg IP are injected, and the rats are included in the study 48 h after the administration of corn oil + Carmustine. Group IV (trimetazidine group) consists of 12 rats. These rats are injected with 2.5 mg/kg per day of trimetazidine (TMZ) IP, administered at the same hour of the day as a single-dose for 3 days. 12 h after the first dose of TMZ, corn oil 2 mL/kg + Carmustine 25 mg/kg IP are injected, and the rats are included in the study 48 h after the administration of corn oil + Carmustine[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

參考文獻(xiàn)

完整儲備液配制表

* 請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;一旦配成溶液,請分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C儲存時,請在6個月內(nèi)使用,-20°C儲存時,請在1個月內(nèi)使用。

可選溶劑 濃度 溶劑體積 質(zhì)量 1 mg 5 mg 10 mg 25 mg
DMSO / H2O 1 mM 4.6718 mL 23.3590 mL 46.7181 mL 116.7951 mL
5 mM 0.9344 mL 4.6718 mL 9.3436 mL 23.3590 mL
10 mM 0.4672 mL 2.3359 mL 4.6718 mL 11.6795 mL
15 mM 0.3115 mL 1.5573 mL 3.1145 mL 7.7863 mL
20 mM 0.2336 mL 1.1680 mL 2.3359 mL 5.8398 mL
25 mM 0.1869 mL 0.9344 mL 1.8687 mL 4.6718 mL
30 mM 0.1557 mL 0.7786 mL 1.5573 mL 3.8932 mL
40 mM 0.1168 mL 0.5840 mL 1.1680 mL 2.9199 mL
50 mM 0.0934 mL 0.4672 mL 0.9344 mL 2.3359 mL
60 mM 0.0779 mL 0.3893 mL 0.7786 mL 1.9466 mL
80 mM 0.0584 mL 0.2920 mL 0.5840 mL 1.4599 mL
100 mM 0.0467 mL 0.2336 mL 0.4672 mL 1.1680 mL

* 備注:如您選擇水作為儲備液,請稀釋至工作液后,再用 0.22 μm 的濾膜過濾除菌后使用。

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的產(chǎn)品:

Your information is safe with us. * Required Fields.

   產(chǎn)品名稱:

 

* 需求量:

* 客戶姓名:

 

* Email:

* 電話:

 

* 公司或機(jī)構(gòu)名稱:

   留言給我們:

Bulk Inquiry

Inquiry Information

產(chǎn)品名稱:
Carmustine
目錄號:
HY-13585
需求量: